Explore the latest resources to stay up to date
about MASH with significant fibrosis (F2/F3)

Expert Sources Stay Informed

Visit additional expert sources to stay educated on MASH
with significant fibrosis as it evolves

Professional organizations:

American Association of Clinical Endocrinology (AACE)
American Association for the Study of Liver Diseases (AASLD)
American College of Gastroenterology (ACG)
American Gastroenterological Association (AGA)
Chronic Liver Disease Foundation (CLDF)
Gastroenterology & Hepatology Advanced Practice Providers (GHAPP)

Patient advocacy organizations:

Global Liver Institute (GLI)
Fatty Liver Foundation (FLF)

Learn about the importance of urgent identification and management

Learn about management

Stay informed as the conversation about MASH with significant fibrosis evolves

Sign up to receive emails for new information on MASH with fibrosis

All fields are required.

By clicking *Subscribe* you certify that you are 18 years of age or older.

By providing your information, you consent to receive corporate communications and other information from Madrigal Pharmaceuticals, including information on MASH and how it may be treated. You hereby give consent to Madrigal, its affiliates, and their agents and representatives to send communications and information to you via the contact information you have provided above. This consent will be in effect until such a time as you opt out of communications from Madrigal.

MASH=metabolic dysfunction-associated steatohepatitis.